medigraphic.com
ISSN 1527-3172 (Digital)

2021, Número 2

<< Anterior Siguiente >>

MEDICC Review 2021; 23 (2)


Using Multiple Cause-of-Death Analysis to Estimate Systemic Autoimmune Disease Mortality Burden in Low- and Middle-Income Countries

Hernández-Negrín H, Roque-Dapresa Y, Martínez-Morales O, Mederos-Portal A

Idioma: Ingles.
Referencias bibliográficas: 54
Paginas: 69-74
Archivo PDF: 148.40 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Scherlinger M, Mertz P, Sagez F, Meyer A,Felten R, Chatelus E, et al. Worldwide trendsin all-cause mortality of auto-immune systemicdiseases between 2001 and 2014. AutoimmunRev [Internet]. 2020 Jun [cited 2020 Jul7];19(6):102531. Available at: http://dx.doi.org/10.1016/j.autrev.2020.102531

  2. Roberts MH, Erdei E. Comparative UnitedStates autoimmune disease rates for 2010-2016by sex, geographic region, and race. AutoimmunRev [Internet]. 2020 Jan [cited 2020 Jul7];19(1):102423. Available at: http://dx.doi.org/10.1016/j.autrev.2019.102423

  3. Thomas SL, Griffi ths C, Smeeth L, Rooney C,Hall AJ. Burden of mortality associated withautoimmune diseases among females in theUnited Kingdom. Am J Public Health. 2010Nov;100(11):2279–87.

  4. Cross M, Smith E, Hoy D, Carmona L, Wolfe F,Vos T, et al. The global burden of rheumatoidarthritis: estimates from the Global Burden ofDisease 2010 study. Ann Rheum Dis [Internet].2014 Jul [cited 2020 Jun 2];73(7):1316–22. Availableat: http://dx.doi.org/10.1136/annrheumdis-2013-204627

  5. Carter EE, Barr SG, Clarke AE. The globalburden of SLE: prevalence, health disparitiesand socioeconomic impact. Nat Rev Rheumatol[Internet]. 2016 Oct [cited 2020 Jun2];12(10):605–20. Available at: http://dx.doi.org/10.1038/nrrheum.2016.137

  6. Royle JG, Lanyon PC, Grainge MJ, Abhishek A,Pearce FA. The incidence, prevalence, and survivalof systemic sclerosis in the UK Clinical PracticeResearch Datalink. Clin Rheumatol [Internet]. 2018Aug [cited 2020 Jul 7];37(8):2103–11. Available at:http://dx.doi.org/10.1007/s10067-018-4182-3

  7. Meyer A, Meyer N, Schaeffer M, GottenbergJ-E, Geny B, Sibilia J. Incidence and prevalenceof infl ammatory myopathies: a systematicreview. Rheumatology. 2015 Jan [cited 2020 Jul7];54(1):50–63. Available at: http://dx.doi.org/10.1093/rheumatology/keu289

  8. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, etal. Epidemiology of primary Sjogren’s syndrome:a systematic review and metaanalysis. AnnRheum Dis [Internet]. 2015 Nov [cited 2020 Jul7];74(11):1983–9. Available at: http://dx.doi.org/10.1136/annrheumdis-2014-205375

  9. Dey D, Sciascia S, Pons-Estel GJ, Ding H,Shen N. Health disparities in rheumatic diseases.Understanding global challenges in Africa,Europe, Latin America, and Asia and proposingstrategies for improvement. Rheum Dis Clin N Am[Internet]. 2021 [cited 2021 Feb 20];47(1):119–32. Available at: https://www.rheumatic.theclinics.com/article/S0889-857X(20)30121-6/pdf

  10. Reyes-Llerena GA, Guibert-Toledano M,Penedo-Coello A, Pérez-Rodríguez A, Baez-Dueñas RM, Charnicharo-Vidal R, et al. Community-based study to estimate prevalence andburden of illness of rheumatic diseases in Cuba:a COPCORD study. J Clin Rheumatol [Internet].2009 Mar [cited 2020 Jun 2];15(2):51–5.Available at: http://dx.doi.org/10.1097/RHU.0b013e31819b61cb

  11. Pincus T, Gibson KA, Block JA. Premature mortality:a neglected outcome in rheumatic diseases?Arthritis Care Res (Hoboken) [Internet]. 2015Aug [cited 2020 Jun 2];67(8):1043–6. Availableat: http://dx.doi.org/10.1002/acr.22554

  12. Abu-Shakra M, Novack V. Mortality and multiplecauses of death in systemic lupus erythematosus -Role of the death certifi cate. J Rheumatol [Internet].2012 Mar [cited 2020 Feb 5];39(3):458–60. Availableat: http://dx.doi.org/10.3899/jrheum.111556

  13. van Kruijsdijk RC, van der Graaf Y, Koffi jberg H,de Borst GJ, Nathoe HM, Jaap Kappelle L, et al.Cause-specifi c mortality and years of life lost inpatients with different manifestations of vasculardisease. Eur J Prev Cardiol [Internet]. 2016Jan [cited 2020 Jul 7];23(2):160–9. Available at:http://dx.doi.org/10.1177/2047487314566998

  14. Toledano E, Candelas G, Rosales Z, MartínezPrada C, León L, Abásolo L, et al. A meta-analysisof mortality in rheumatic diseases. ReumatolClin [Internet]. 2012 Nov–Dec [cited 2020 Jul7];8(6):334–41. Available at: http://dx.doi.org/10.1016/j.reuma.2012.05.006

  15. Cardiel MH, Ambriz Murillo Y. Epidemiología delas enfermedades infl amatorias reumatológicas.In: Alba Fériz R, Muñoz Louis R, Espinoza LR,Khamashta M, Matucci-Cerinic M, Sanmartí R,editors. Enfermedades Infl amatorias Reumatológicas.Bogotá: Producciones Científi cas Ltda;2016. Spanish.

  16. Woolf AD, Vos T, March L. How to measure theimpact of musculoskeletal conditions. Best PractRes Clin Rheumatol [Internet]. 2010 [cited 2020 Jun2];24(6):723–32. Available at: http://dx.doi.org/10.1016/j.berh.2010.11.002

  17. Falasinnu T, Rossides M, Chaichian Y, SimardJF. Do death certifi cates underestimate the burdenof rare diseases? The example of systemiclupus erythematosus mortality, Sweden, 2001-2013. Public Health Rep [Internet]. 2018 [cited2020 Jun 2];133(4):481–8. Available at: http://dx.doi.org/10.1177/0033354918777253

  18. Kiadaliri AA, Turkiewicz A, Englund M. Mortalityfrom musculoskeletal disorders includingrheumatoid arthritis in southern Sweden: Amultiple-cause-of-death analysis, 1998–2014. JRheumatol [Internet]. 2017 May [cited 2020 Jun2];44(5):571–9. Available at: http://dx.doi.org/10.3899/jrheum.161219

  19. Egidi V, Salvatore MA, Rivellini G, D’AngeloS. A network approach to studying cause-ofdeathinterrelations. Demogr Res [Internet]. 2018 Jan 26 [cited 2020 Jul 7];38(Art. 16):373–400. Available at: http://dx.doi.org/10.4054/DemRes.2018.38.16

  20. Santo AH, Souza JMP, Pinheiro CE, Souza DC,Sato EI. Trends in dermatomyositis- and polymyositisrelated mortality in the state of São Paulo,Brazil, 1985-2007: multiple cause-of-death analysis.BMC Public Health [Internet]. 2010 Oct 11[cited 2020 Jul 15];10:597. Available at: http://dx.doi.org/10.1186/1471-2458-10-597

  21. Sato EI, Souza DC, Santo AH. [Mortality profile related to systemic lupus erythematosus: amultiple cause-of-death analysis]. J Rheumatol[Internet]. 2012 [cited 2020 Jul 15];39(3):496–503. Available at: https://www.jrheum.org/content/39/3/496.long

  22. Yen EY, Singh RR. Brief report: Lupus-anunrecognized leading cause of death in youngfemales: a population-based study using nationwidedeath certifi cates, 2000-2015. ArthritisRheumatol [Internet]. 2018 Aug [cited 2020 Jul15];70(8):1251–5. Available at: http://dx.doi.org/10.1002/art.40512

  23. Elhai M, Meune C, Boubaya M, Avouac J,Hachulla E, Balbir-Gurman A, et al. Mapping andpredicting mortality from systemic sclerosis. AnnRheum Dis [Internet]. 2017 Nov [cited 2020 Jul17];76(11):1897–905. Available at: http://dx.doi.org/10.1136/annrheumdis-2017-211448

  24. Pinheiro FAG, Souza DCC, Sato EI. A study ofmultiple causes of death in rheumatoid arthritis.J Rheumatol [Internet]. 2015 Dec [cited 2020 Jul15];42(12):2221–8. Available at: http://dx.doi.org/10.3899/jrheum.150166

  25. Thomas G, Mancini J, Jourde-Chiche N, SarlonG, Amoura Z, Harlé JR, et al. Mortality associatedwith systemic lupus erythematosus in Franceassessed by multiple-cause-of-death analysis.Arthritis Rheumatol [Internet]. 2014 Sep [cited2020 Jul 15];66(9):2503–11. Available at: http://dx.doi.org/10.1002/art.38731

  26. Poubel Vieira de Rezende R, Altenburg GismondiR, Cesar Maleh H, de Miranda Coelho E, SartoriVieira C, Garcia Rosa M, et al. Distinct mortalityprofi le in systemic sclerosis: a death certifi catestudy in Rio de Janeiro, Brazil (2006–2015)using a multiple causes of death analysis. ClinRheumatol [Internet]. 2019 Jan [cited 2020 Jul15];38(1):189–94. Available at: http://dx.doi.org/10.1007/s10067-017-3951-8

  27. Hernández-Negrín H, Padilla-Cueto D, MartínezMorales O. Tendencia creciente en la mortalidadpor lupus eritematoso sistémico en América Latinacomo expresión de las desigualdades socialesen salud. [Increasing trend in mortality fromsystemic lupus erythematosus in Latin Americaas an expression of social disparities in health].Reumatol Clin [Internet]. 2020 Aug 10 [cited 2020Jul 7]. Available at: http://dx.doi.org/10.1016/j.reuma.2020.07.004. Spanish, English.

  28. Tazi Mezalek Z, Bono W. Challenges for lupusmanagement in emerging countries. Presse Med.2014 Jun [cited 2020 Jul 15];43(6 Pt 2):e209–e20. Available at: http://dx.doi.org/10.1016/j.lpm.2014.04.002

  29. Mesa Machado AC, Tejeiro Fernández A. Causasmúltiples de muerte. Rev Cub Hig Epidemiol[Internet]. 1998 Aug [cited 2020 Jun1];36(2):116–26. Available at: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S1561-30031998000200004&lng=es&nrm=iso.Spanish.

  30. Seuc AH, Fernández L, Mirabal-Sosa M,González CA. Cuban application of two methodsfor analyzing multiple causes of death. MEDICCRev. 2018 Jul;20(3):30–5.

  31. Fernández González L, Seuc Jo AH, RodríguezGarcía CA. Método de mortalidad ponderadosegún múltiples causas de muerte. RevFinlay [Internet]. 2019 Oct [cited 2020 May29];9(3):197–209. Available at: http://www.revfinlay.sld.cu/index.php/finlay/article/view/701.Spanish.

  32. Mathers CD, Ma Fat D, Inoue M, Rao C, LópezAD. Counting the dead and what they died from:an assessment of the global status of causeof death data. Bull World Health Org. 2005Mar;83(3):171–7.

  33. National Health Statistics and Medical RecordsDivision (CU). 10 primeras causas de muertepor grupos de edad y sexo en el adulto mayor.Cuba 2008 [Internet]. Havana: Ministry of PublicHealth (CU); 2009 Aug [cited 2020 Dec 10]. 4 p.Available at: http://www.sld.cu/galerias/pdf/sitios/dne/adulto_mayor_10_1ras_causas_2008.pdf.Spanish.

  34. INFOMED [Internet]. Havana: Ministry of PublicHealth (CU); c1999–2021. Anuario Estadísticode Salud del Ministerio de Salud Pública; [cited2020 Dec 10]. Available at: http://www.bvscuba.sld.cu/2017/11/20/anuario-estadistico-de-salud-de-cuba/. Spanish.

  35. World Health Organization. International Classifi -cation of Diseases and related health problems,10th revision: Volume II. Geneva: World HealthOrganization; 1993.

  36. Estrategia en enfermedades reumáticas y musculoesqueléticasdel Sistema Nacional de Salud.Madrid: Ministerio de Sanidad, Servicios Socialese Igualdad; 2013. Spanish.

  37. Pérez Venegas JJ, Lama Herrera CM, SanzAmores R, Martínez Concepción E, AbadRamírez R, Aguiar García F, et al. Plan Andaluzde Enfermedades Reumáticasy y Musculoesqueléticas.Sevilla: Junta de Andalucía,Consejería de Salud; 2018. p. 79. Spanish.

  38. National Association of Chronic Disease Directors;Center for Disease Control and Prevention;Lupus Foundation of America. National PublicHealth Agenda for Lupus. A Blueprint for Action.Atlanta: Center for Disease Control and Prevention;2015. 31 p.

  39. Cardiel MH. Presente y futuro de las enfermedadesreumáticas en Iberoamérica. ¿Estamospreparados para hacerles frente? ReumatolClin [Internet]. 2011 Sep–Oct [cited 2020 Jul15];7(5):279–80. Available at: http://dx.doi.org/10.1016/j.reuma.2010.12.009. Spanish.

  40. Morales Ojeda R, Mas Bermejo P, Castell-FloritSerrate P, Arocha Mariño C, Valdivia Onega NC,Druyet Castillo D, et al. Transformaciones en elsistema de salud en Cuba y estrategias actualespara su consolidación y sostenibilidad. Rev PanamSalud Publica [Internet]. 2018 Apr [cited 2020Dec 10];42:e25. Available at: http://dx.doi.org/10.26633/RPSP.2018.25. Spanish, English.

  41. Corratgé Delgado H. Objetivos de Trabajo y Criteriosde Medidas para 2020. Ministerio de SaludPública. INFODIR [Internet]. 2020 [cited 2020Jun 1]:31. Available at: http://revinfodir.sld.cu/index.php/infodir/article/view/757. Spanish.

  42. Mitratza M, Klijs B, Hak AE, Kardaun JWPF,Kunst AE. Systemic autoimmune disease asa cause of death: mortality burden and comorbidities.Rheumatology (Oxford) [Internet]. 2021Mar 2 [cited 2020 Dec 10];60(3):1321–30. Availableat: http://dx.doi.org/10.1093/rheumatology/keaa537

  43. Benchimol EI, Smeeth L, Guttmann A, HarronK, Moher D, Petersen I, et al. The REporting ofstudies Conducted using Observational Routinely-collected health Data (RECORD) Statement.PLoS Med [Internet]. 2015 Oct 6 [cited 2020 Dec10];12(10):e1001885. Available at: http://dx.doi.org/10.1371/journal.pmed.1001885

  44. Venero Fernández SJ, Bonet Gorbea MH, LageDávila A, Macías Agraham C, Suárez Medina M.Mortalidad por inmunopatologías en Cuba, 1989-2003. Havana: National Hygiene, Epidemiology andMicrobiology Institute (CU); 2008 Jan. Spanish.

  45. Gomes T, Tadrous M, Mamdani MM, PatersonJM, Juurlink DN. The burden of opioid-relatedmortality in the United States. JAMA NetwOpen [Internet]. 2018 Jun 1 [cited 2020 Dec10];1(2):e180217. Available at: http://dx.doi.org/10.1001/jamanetworkopen.2018.0217

  46. Barbieri M, Désesquelles A, Egidi V, Demuru E,Frova L, Mesle F, et al. Obesity-related mortalityin France, Italy, and the United States: a comparisonusing multiple cause-of-death analysis. Int JPublic Health [Internet]. 2017 May 11 [cited 2020Dec 13];62(6):623–9. Available at: http://dx.doi.org/10.1007/s00038-017-0978-1

  47. Adair T, Lopez AD. The role of overweight andobesity in adverse cardiovascular diseasemortality trends: an analysis of multiple causeof death data from Australia and the USA.BMC Med [Internet]. 2020 Aug 4 [cited 2020Dec 13];18(1):199. Available at: http://dx.doi.org/10.1186/s12916-020-01666-y

  48. Santo AH, Puech-Leão P, Krutman M. Trends inaortic aneurysm- and dissection-related mortalityin the state of São Paulo, Brazil, 1985–2009: multiple-cause-of-death analysis. BMC Public Health[Internet]. 2012 Oct 10 [cited 2020 Dec 13];12:859.Available at: http://dx.doi.org/10.1186/14712458-12-859

  49. Barco S, Valerio C, Ageno W, Cohen AT, GoldhaberSZ, Hunt BJ, et al. Age-sex specifi c pulmonaryembolism-related mortality in the USA andCanada, 2000–18: an analysis of the WHO MortalityDatabase and of the CDC Multiple Causeof Death database. Lancet Respir Med [Internet].2020 Jan 1 [cited 2020 Dec 10];9(1):33–42.Available at: http://dx.doi.org/10.1016/S2213-2600(20)30417-3

  50. Pechholdová M. Sepsis-related mortality inthe Czech Republic: multiple causes of deathanalysis. Epidemiol Mikrobiol Imunol. 2017 Summer;66(2):73–9.

  51. Santo AH. Causes of death and mortality trendsrelated to hemophilia in Brazil, 1999 to 2016.Hematol Transfus Cell Ther [Internet]. 2020 Jun4 [cited 2020 Dec 13];S2531-1379(20)30056-0.Available at: http://dx.doi.org/10.1016/j.htct.2020.02.003

  52. Avouac J, Amrouche F, Meune C, Rey G, KahanA, Allanore Y. Mortality profi le of patients withrheumatoid arthritis in France and its changein 10 years. Semin Arthritis Rheum [Internet].2017 Apr [cited 2020 Dec 13];46(5):537–43.Available at: http://dx.doi.org/10.1016/j.semarthrit.2016.10.007

  53. Falasinnu T, Chaichian Y, Simard JF. Impact ofsex on systemic lupus erythematosus-relatedcauses of premature mortality in the UnitedStates. J Womens Health (Larchmt) [Internet].2017 Nov [cited 2020 Dec 13];26(11):1214–21. Available at: http://dx.doi.org/10.1089/jwh.2017.6334

  54. Souza DCC, Santo AH, Sato EI. Trends in systemiclupus erythematosus mortality rates in thestate of São Paulo, Brazil from 1985 to 2004. ClinExp Rheumatol. 2010 Jul–Aug;28(4):519–24.




2020     |     www.medigraphic.com